Current Status and Future Direction of Japan's Clinical Trial for Malignant Pleural Mesothelioma
Seiki Hasegawa +8 more
openalex +2 more sources
SATB2 Induces Malignant Transformation and Cancer Stem Cell Characteristics, and Inhibition of Its Expression Reverses Drug Resistance in Mesothelioma. [PDF]
Brown C +6 more
europepmc +1 more source
FDG and FAPI PET-based response evaluation to reduced-dose nivolumab in pleural mesothelioma: A case report. [PDF]
Bentestuen M +5 more
europepmc +1 more source
When a hydrocele is more than a hydrocele: Warning symptoms and signs of malignant mesothelioma of the tunica vaginalis testis. [PDF]
Cornfield J, Lee M, Sharifi R.
europepmc +1 more source
Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study. [PDF]
Sobeih ME, Helal M, Yahia M, Khorshid O.
europepmc +1 more source
Beyond Asbestos: Malignant Pleural Mesothelioma Revealing Lynch Syndrome Through Mismatch Repair Deficiency. [PDF]
Vivanco S +5 more
europepmc +1 more source
Mechanisms and functions of chemerin in cancer: Potential roles in therapeutic intervention [PDF]
Pachynski, Russell K +2 more
core +1 more source
Genomic sequencing of multicystic mesothelioma finds cohesin complex mutations associated with disease recurrence in patients referred for cytoreductive surgery and HIPEC. [PDF]
Gibson J +17 more
europepmc +1 more source
Projecting future mortality risk of pleural mesothelioma in Italy (2020-2034): Bayesian age-period-cohort analysis over 40 years of death registration. [PDF]
Sartore A +9 more
europepmc +1 more source

